Prevention and Population Research Committee

The Prevention and Population Research Committee (PPRC) supports a broad portfolio of prevention and population research aimed at understanding the epidemiology of cancer, cancer risk, incidence and survival and preventative interventions.

Research areas

PPRC Programme Awards can be awarded in one or more of the following areas:

• Population-based studies, including classical, clinical and molecular epidemiological approaches, to help understand risk and disease aetiology, and to test and validate strategies to improve the prevention and control of cancer in patients and the public.

• Incidence rates of cancer, including changes over time and geographies. Investigation into the changes in cancer survival, driven by risk factors or other relevant factors.

• Methodological and statistical research relating to prevention and population sciences.

• Population-level epidemiological studies of secondary physical effects of cancer treatment.

• Risk stratification and associated cancer prevention studies, including identification of high-risk groups for whom preventative interventions would be beneficial and in which preventative intervention research could be conducted.

• Exploratory and confirmatory clinical trials seeking to test the efficacy and safety of chemopreventive agents.

• Development and evaluation of behavioural and lifestyle interventions to support prevention of cancer, including cancer recurrence, across a range of risk factors, which may include tobacco, alcohol, physical activity, sedentary behaviour, obesity and UV exposure (individual or population level).

• Screening as a form of prevention, including population-level trials of screening approaches.

• Policy-focused research to help develop Cancer Research UK’s policies and advocacy strategies concerning cancer prevention, including policy research on tobacco control.

PPRC funds prevention and population research across all cancer types, treatment modalities and stages in the patient journey, while prioritising the objectives set out in our Research Strategy.

How proposals are judged

Applications are judged on the basis of scientific excellence, innovation and relevance to cancer research. The Committee and its expert review panels meet twice a year and assess all applications on the basis of their scientific and strategic importance, whilst also studying the expert peer review which is collated for each grant.


Sign up to mailing list

To find out about exciting opportunities in prevention and population research, including our new strategy, funding initiatives and upcoming events please sign up to our mailing list

Sign Up

Observing funding panels and committees

As part of our commitments to supporting the next generation of researchers and equality, diversity and inclusion in research, we're offering early- to mid-career researchers the opportunity to observe our panel and committee meetings across our funding remit. This scheme will include positive action to offer individuals from underrepresented groups priority places to overcome the underrepresentation that has been highlighted by our diversity data report.  

Through this experience we hope you can: 

  • Understand how grant funding decisions are made to ensure we fund the best quality research
  • Develop your own successful research proposals in the future 
  • Help develop your skills as peer reviewers 
  • Have the opportunity to give feedback to us to help improve our review processes

Our prevention research strategy

Two people exercising, HPV vaccine vial and cervical cancer cell

Our prevention strategy outlines how we’ll work with our research community to create a world where many more types of cancer are prevented from developing. 

Committee and panel members


Professor Kay-Tee Khaw – University of Cambridge


Professor Mark Beresford – Royal United Hospital Bath


Professor Krishnan Bhaskaran - London School of Hygiene and Tropical Medicine

Professor Sarah Blagden - University of Oxford

Ally Boyle - Patient and Public Representative

Professor Karen Brown - University of Leicester

Professor Nilanjan Chatterjee - John Hopkins University 

Professor Helen Coleman – Queen's University Belfast

Professor Amanda Cross – Imperial College London

Dr Filippos Filippidis – Imperial College London

Dr Mattias Johansson – International Agency for Research on Cancer

Professor Graham Moore – Cardiff University

Professor Marcus Munafo – University of Bristol

Professor Richard Neal - University of Exeter

Dr Michael Pollak - McGill University

Professor Peter Sasieni - King's College London

Professor Linda Sharp – Newcastle University

Dr Alex Smith – University of York

Dr Eva Szabo - The National Cancer Institute

Professor Dawn Teare – Newcastle University

Professor Evropi Theodoratou - University of Edinburgh

Lisa Townsend - Patient and Public Representative

Professor Mark Tully - Ulster University

Professor Alicja Wolk – Karolinska Institutet

Expert Review Panel A


Professor Amanda Cross – Imperial College London


Professor Karen Brown – University of Leicester

Expert Review Panel B


Professor Marcus Munafo – University of Bristol


Professor Linda Sharp – Newcastle University


Standing Panel members

Professor Rebecca Hardy - Loughborough University

Dr Felix Naughton - University of East Anglia



Ally Boyle

Lisa Townsend

Panel members

Dr Alison Allam

Dr Catherine Biggs

Phil Buck

Sue Duncombe

Musa Garba

Katherine Glen

Jax Hamil

Claire James

Angela King

Emily Lam

Patrick McGuire

Liz Middleton

Stella O'Brien

Phil Pocock

Malcolm Rhodes

Contact for this committee

Dr David Crosby


Dr David Crosby

Head of Prevention and Early Detection Research

Tel +44 (0) 20 3469 6086


Dr Anbalakan Paramasivam

Research Programme Manager 


Tel: +44 (0) 20 3469 8824


Dr Kirsty Naylor

Research Grants Manager


Tel: +44 (0) 20 3469 5285

Other opportunities for prevention and population researchers

We support a broad portfolio of prevention and population research aimed at understanding the epidemiology of cancer, cancer risk, incidence and survival and preventative interventions.

We fund investigator-led projects, partnership initiatives, research facilities and resources, and we have a range of opportunities to help you develop your research career.